Status:
NOT_YET_RECRUITING
Genetic Predisposition to High Blood Pressure
Lead Sponsor:
Linkoeping University
Conditions:
Hypertension
Primary Aldosteronism
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Primary aldosteronism (PA) is a known but underdiagnosed cause of high blood pressure. It is estimated that more than 10% of all people with high blood pressure (HT) suffer from PA, which is often cau...
Eligibility Criteria
Inclusion
- patients that participated in the SCAPIS study
- patients that have a particular genetic variant
- patients that have hypertension
Exclusion
- patients who do not want to participate
- patients who cannot give consent
- patients who are too sick to be operated
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT07181213
Start Date
January 1 2026
End Date
December 31 2027
Last Update
September 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.